New York, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The global therapeutic apheresis market is experiencing a surge in demand, fueled by a confluence of factors including the rising prevalence of chronic ...
Cholesterol bloodstream An undesirable lipoprotein effect of LDL apheresis is the lowering of high-density lipoprotein (HDL) cholesterol. Proprotein convertase subtilisin/kexin type 9 (PCSK9) ...
New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Apheresis Consumables And Equipment Global Market Report 2021 ...
The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...
The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing ...
(MENAFN- GlobeNewsWire - Nasdaq) The apheresis market is driven by rising demand for blood components, advancements in apheresis technology, and increasing prevalence of chronic diseases. Growing ...
The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing ...
LONDON, May 24, 2023 /PRNewswire/ -- Apheresis is referred to a type of medical technology which facilitates the separation and selective removal or collection of specific blood components from a ...
HDL was reduced from 1.0 ± 0.2 mmol/L pre- to 0.5 ± 0.1 mmol/L post-apheresis (p = 0.03). It increased following apheresis and then remained constant throughout the evolocumab treatment. Lp(a) ...
New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Apheresis Consumables And Equipment Global Market Report 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback